The generic challenge: understanding patents, FDA and pharmaceutical life-cycle management
Gespeichert in:
1. Verfasser: | |
---|---|
Format: | Buch |
Sprache: | English |
Veröffentlicht: |
Boca Raton, Fla.
Brown Walker Press
2014
|
Ausgabe: | 4. ed. |
Schlagworte: | |
Beschreibung: | XXIV, 194 S. Ill. |
ISBN: | 1612337287 9781612337289 |
Internformat
MARC
LEADER | 00000nam a2200000 c 4500 | ||
---|---|---|---|
001 | BV042075323 | ||
003 | DE-604 | ||
005 | 20141017 | ||
007 | t | ||
008 | 140916s2014 a||| |||| 00||| eng d | ||
020 | |a 1612337287 |9 1-61233-728-7 | ||
020 | |a 9781612337289 |9 978-1-61233-728-9 | ||
035 | |a (DE-599)BVBBV042075323 | ||
040 | |a DE-604 |b ger |e rakwb | ||
041 | 0 | |a eng | |
049 | |a DE-M382 | ||
100 | 1 | |a Voet, Martin A. |e Verfasser |4 aut | |
245 | 1 | 0 | |a The generic challenge |b understanding patents, FDA and pharmaceutical life-cycle management |c Martin A. Voet |
250 | |a 4. ed. | ||
264 | 1 | |a Boca Raton, Fla. |b Brown Walker Press |c 2014 | |
300 | |a XXIV, 194 S. |b Ill. | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
650 | 4 | |a Drugs / Generic substitution / Law and legislation / United States | |
650 | 4 | |a Drugs / United States / Generic substitution / Patents | |
650 | 4 | |a Patent extensions / United States | |
650 | 4 | |a Pharmaceutical biotechnology / Patents | |
650 | 4 | |a Pharmaceutical biotechnology / Law and legislation | |
650 | 7 | |a Drugs / Generic substitution |2 fast | |
650 | 7 | |a Drugs / Generic substitution / Law and legislation |2 fast | |
650 | 7 | |a Patent extensions |2 fast | |
650 | 7 | |a Pharmaceutical biotechnology |2 fast | |
650 | 7 | |a Pharmaceutical biotechnology / Law and legislation |2 fast | |
650 | 4 | |a Recht | |
651 | 7 | |a United States |2 fast | |
651 | 4 | |a USA | |
999 | |a oai:aleph.bib-bvb.de:BVB01-027516505 |
Datensatz im Suchindex
_version_ | 1804152522530619393 |
---|---|
any_adam_object | |
author | Voet, Martin A. |
author_facet | Voet, Martin A. |
author_role | aut |
author_sort | Voet, Martin A. |
author_variant | m a v ma mav |
building | Verbundindex |
bvnumber | BV042075323 |
ctrlnum | (DE-599)BVBBV042075323 |
edition | 4. ed. |
format | Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01502nam a2200421 c 4500</leader><controlfield tag="001">BV042075323</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20141017 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">140916s2014 a||| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1612337287</subfield><subfield code="9">1-61233-728-7</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781612337289</subfield><subfield code="9">978-1-61233-728-9</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV042075323</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-M382</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Voet, Martin A.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">The generic challenge</subfield><subfield code="b">understanding patents, FDA and pharmaceutical life-cycle management</subfield><subfield code="c">Martin A. Voet</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">4. ed.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Boca Raton, Fla.</subfield><subfield code="b">Brown Walker Press</subfield><subfield code="c">2014</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XXIV, 194 S.</subfield><subfield code="b">Ill.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs / Generic substitution / Law and legislation / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs / United States / Generic substitution / Patents</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Patent extensions / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical biotechnology / Patents</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical biotechnology / Law and legislation</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Drugs / Generic substitution</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Drugs / Generic substitution / Law and legislation</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Patent extensions</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Pharmaceutical biotechnology</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Pharmaceutical biotechnology / Law and legislation</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Recht</subfield></datafield><datafield tag="651" ind1=" " ind2="7"><subfield code="a">United States</subfield><subfield code="2">fast</subfield></datafield><datafield tag="651" ind1=" " ind2="4"><subfield code="a">USA</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-027516505</subfield></datafield></record></collection> |
geographic | United States fast USA |
geographic_facet | United States USA |
id | DE-604.BV042075323 |
illustrated | Illustrated |
indexdate | 2024-07-10T01:12:03Z |
institution | BVB |
isbn | 1612337287 9781612337289 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-027516505 |
open_access_boolean | |
owner | DE-M382 |
owner_facet | DE-M382 |
physical | XXIV, 194 S. Ill. |
publishDate | 2014 |
publishDateSearch | 2014 |
publishDateSort | 2014 |
publisher | Brown Walker Press |
record_format | marc |
spelling | Voet, Martin A. Verfasser aut The generic challenge understanding patents, FDA and pharmaceutical life-cycle management Martin A. Voet 4. ed. Boca Raton, Fla. Brown Walker Press 2014 XXIV, 194 S. Ill. txt rdacontent n rdamedia nc rdacarrier Drugs / Generic substitution / Law and legislation / United States Drugs / United States / Generic substitution / Patents Patent extensions / United States Pharmaceutical biotechnology / Patents Pharmaceutical biotechnology / Law and legislation Drugs / Generic substitution fast Drugs / Generic substitution / Law and legislation fast Patent extensions fast Pharmaceutical biotechnology fast Pharmaceutical biotechnology / Law and legislation fast Recht United States fast USA |
spellingShingle | Voet, Martin A. The generic challenge understanding patents, FDA and pharmaceutical life-cycle management Drugs / Generic substitution / Law and legislation / United States Drugs / United States / Generic substitution / Patents Patent extensions / United States Pharmaceutical biotechnology / Patents Pharmaceutical biotechnology / Law and legislation Drugs / Generic substitution fast Drugs / Generic substitution / Law and legislation fast Patent extensions fast Pharmaceutical biotechnology fast Pharmaceutical biotechnology / Law and legislation fast Recht |
title | The generic challenge understanding patents, FDA and pharmaceutical life-cycle management |
title_auth | The generic challenge understanding patents, FDA and pharmaceutical life-cycle management |
title_exact_search | The generic challenge understanding patents, FDA and pharmaceutical life-cycle management |
title_full | The generic challenge understanding patents, FDA and pharmaceutical life-cycle management Martin A. Voet |
title_fullStr | The generic challenge understanding patents, FDA and pharmaceutical life-cycle management Martin A. Voet |
title_full_unstemmed | The generic challenge understanding patents, FDA and pharmaceutical life-cycle management Martin A. Voet |
title_short | The generic challenge |
title_sort | the generic challenge understanding patents fda and pharmaceutical life cycle management |
title_sub | understanding patents, FDA and pharmaceutical life-cycle management |
topic | Drugs / Generic substitution / Law and legislation / United States Drugs / United States / Generic substitution / Patents Patent extensions / United States Pharmaceutical biotechnology / Patents Pharmaceutical biotechnology / Law and legislation Drugs / Generic substitution fast Drugs / Generic substitution / Law and legislation fast Patent extensions fast Pharmaceutical biotechnology fast Pharmaceutical biotechnology / Law and legislation fast Recht |
topic_facet | Drugs / Generic substitution / Law and legislation / United States Drugs / United States / Generic substitution / Patents Patent extensions / United States Pharmaceutical biotechnology / Patents Pharmaceutical biotechnology / Law and legislation Drugs / Generic substitution Drugs / Generic substitution / Law and legislation Patent extensions Pharmaceutical biotechnology Recht United States USA |
work_keys_str_mv | AT voetmartina thegenericchallengeunderstandingpatentsfdaandpharmaceuticallifecyclemanagement |